News for XBiotech, Inc. (XBIT)

News for XBiotech, Inc.
Date Headline
Dec 12, 2018 08:30 AM XBiotech’s Results from Phase 2 Atopic Dermatitis Study Suggest New Drug to Treat Skin Disease
Dec 03, 2018 08:15 AM XBiotech Announces Successful Completion of GMP Audit
Nov 23, 2018 07:35 AM Detailed Research: Economic Perspectives on Jason Industries, XBiotech, Dynatronics, Evolving, CTI BioPharma, and Charles & Colvard — What Drives Growth in Today's Competitive Landscape
Oct 31, 2018 04:05 PM XBiotech Highlights Third Quarter Developments for 2018
Oct 05, 2018 08:00 AM XBiotech Announces Enrollment Completion in Phase 2 Multicenter Study Evaluating Bermekimab in Patients with Atopic Dermatitis
Sep 26, 2018 08:00 AM XBiotech Announces Granting of European Patent for Treatment of Inflammatory Skin Diseases
Sep 24, 2018 08:30 AM XBiotech Announces Completion of U.S. Enrollment in Phase 2 Multicenter Study Evaluating Bermekimab in Patients with Hidradenitis Suppurativa
Sep 20, 2018 08:00 AM XBiotech Announces Addition of Top Dermatologist and Researcher Dr. Alice Gottlieb to its Team
Jul 10, 2018 08:01 AM XBiotech Announces First Patient in Phase 2 Study Evaluating Subcutaneous MABp1 in Patients with Hidradenitis Suppurativa
May 22, 2018 08:01 AM XBiotech Announces First Patient in Phase 2 Study Evaluating MABp1 in Patients with Atopic Dermatitis